Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
about
Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiesEffect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out micePurified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPHIsolation and characterization of human apolipoprotein M-containing lipoproteinsDNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart diseaseAssociation between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) studyOxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological roleAntioxidants, inflammation and cardiovascular diseaseThe human paraoxonase gene cluster as a target in the treatment of atherosclerosisInflammation, infection, cancer and all that…the role of paraoxonasesTo hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolaseModulation of paraoxonases during infectious diseases and its potential impact on atherosclerosisCholesterol, inflammation and innate immunityHydrolysis of platelet-activating factor by human serum paraoxonaseEffects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression.Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newbornsParticulate matter and atherosclerosis: role of particle size, composition and oxidative stressClinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosisHuman paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological rolesHDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approachA high throughput biochemical fluorometric method for measuring lipid peroxidation in HDLAn assessment of antioxidant status in patients with carbon monoxide poisoningAir pollution and circulating biomarkers of oxidative stressNeuroprotective effect of nitric oxide donor isosorbide-dinitrate against oxidative stress induced by ethidium bromide in rat brainABCG1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions.Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis.PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activityIn vivo administration of BL-3050: highly stable engineered PON1-HDL complexesOxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6.Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.Oxidative risk for atherothrombotic cardiovascular disease.Paraoxonase 2 protein is spatially expressed in the human placenta and selectively reduced in labourCitric acid effects on brain and liver oxidative stress in lipopolysaccharide-treated mice.Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease.Paraoxonase genes and disease.Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescentsHigh density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis.Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endotheliumDecreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairmentParaoxonase 1 polymorphism Q192R affects the pro-inflammatory cytokine TNF-alpha in healthy males
P2860
Q24298200-25BD860B-39D6-4189-9BAC-6606D50077A3Q24300591-F5F5E321-AA5C-4467-A6C4-CDE82C27E41DQ24302314-0605C3F8-F698-4D67-B260-9FFB414155B8Q24336276-71A68F72-1E3A-4421-8022-56A079A0D084Q24538662-D8E4E124-7BCB-481A-AF3C-E0344FFE767DQ24615705-4377ED0C-114B-4A0D-AD7E-AEB7F2FE5196Q26747100-76A23D93-A127-4D82-B9EE-EA7D5F956ECFQ26823009-90D5334D-9967-4D1E-B8D6-96C5E6A95333Q26824356-C5D2B95B-2BB1-439D-A546-24500BFDEC91Q26849832-4179FCBA-C749-4E24-9CDA-9400AB3AD125Q26865969-A78AC8BE-2446-4817-A76F-02286517642BQ27004131-0C4ED316-B18B-40A5-B12A-E30D31ED6660Q28086912-13E7922E-D4E6-4432-929B-39D93D628924Q28347908-DF950B46-1E74-4405-89DA-27CCE8FE5A3CQ28364175-673C9531-51F7-4D1F-9FB1-090CD7B57834Q28389567-F398A5C0-AA8F-4300-B71E-7EBCCE2B204CQ28391543-004851F9-632E-4AD4-A714-89BA37AC2ADBQ28392768-5237D53B-77F5-4A2E-8E11-9B7508D3E1F3Q28395898-7703F946-B9EF-4EA9-97D3-48A3A3A4DE4FQ28481613-5C507741-F928-4AC0-A490-CFF9F3865746Q28544713-E320E6E0-214E-4B38-B439-314C180A318FQ28654645-6408C000-0A65-4E6A-A33E-857B82CEFF26Q28708793-D0DBB1A7-FCFF-47B5-AF2B-5AB77605ACF7Q28831295-B1A641F7-1010-4632-BFC1-33F9FD42A022Q30432802-EE21F76F-3CB0-482A-9308-DDF9D74F18B9Q30441413-460345FC-B65B-450C-AE06-B755346263EBQ30655573-100E7C81-FC15-4483-87A6-CF778E35B869Q30891417-096D3E91-037C-45E9-85AE-F71C8F4E76D0Q31464758-B31CC7B5-C95B-41D0-A07A-7DAEDA9E668AQ33497323-82BC43C4-A57D-472A-8215-334F36207FA7Q33554184-EC8B5FCF-E4BB-4A18-BFB8-BC7A6184D757Q33590383-AA7E8185-F185-48ED-9D2E-34836A1161AFQ33631601-7BB714A6-613D-43B7-B1CD-7A2894427A40Q33642534-F9DDA952-0494-4505-A5C2-DE05D851B3CFQ33708692-3706C56B-27AE-4020-8641-C3F4602E8BF9Q33750456-C037E87E-973C-4C29-A22E-9EC102CEC40FQ33806840-150379A8-5A0B-462B-B597-303F538B96B7Q33853451-8FC8A980-BB57-4BED-8149-E6711853106EQ33878870-C4B6960B-81C1-4426-A778-E2A4BD655B0FQ33898495-A2AB267C-6B36-4CA1-BF2D-AA6CE6321D7B
P2860
Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Protective effect of high dens ...... dized low density lipoprotein.
@ast
Protective effect of high dens ...... dized low density lipoprotein.
@en
type
label
Protective effect of high dens ...... dized low density lipoprotein.
@ast
Protective effect of high dens ...... dized low density lipoprotein.
@en
prefLabel
Protective effect of high dens ...... dized low density lipoprotein.
@ast
Protective effect of high dens ...... dized low density lipoprotein.
@en
P2093
P2860
P356
P1476
Protective effect of high dens ...... dized low density lipoprotein.
@en
P2093
A D Watson
A M Fogelman
J A Berliner
P2860
P304
P356
10.1172/JCI118359
P407
P577
1995-12-01T00:00:00Z